Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs

OBJECTIVE: The objective of this study is to examine the risk of serious infections (SIs) associated with biological disease‐modifying antirheumatic drugs (bDMARDs) compared with conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs) in patients with rheumatoid arthritis (RA). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozen, Gulsen, Pedro, Sofia, England, Bryant R., Mehta, Bella, Wolfe, Frederick, Michaud, Kaleb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858027/
https://www.ncbi.nlm.nih.gov/pubmed/31777822
http://dx.doi.org/10.1002/acr2.11064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858027/
https://www.ncbi.nlm.nih.gov/pubmed/31777822
http://dx.doi.org/10.1002/acr2.11064

Ejemplares similares